Nephrogenic diabetes insipidus associated with temozolomide therapy in a patient with grade IV astrocytoma
Temozolomide (TMZ), an alkylating agent used in glioblastoma multiforme and anaplastic astrocytoma treatment, is generally associated with side effects like myelosuppression and nausea. This case report describes a rare occurrence of nephrogenic diabetes insipidus (NDI) in a 45-year-old male with gr...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SMC MEDIA SRL
2025-05-01
|
| Col·lecció: | European Journal of Case Reports in Internal Medicine |
| Matèries: | |
| Accés en línia: | https://www.ejcrim.com/index.php/EJCRIM/article/view/5463 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|